Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study (Q71603077)
Jump to navigation
Jump to search
scientific article published on 01 December 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study |
scientific article published on 01 December 1995 |
Statements
Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study (English)
Egsmose C
Lund B
Borg G
Pettersson H
Berg E
Brodin U
1 December 1995